Open-house rebate agreement for Rasagilin
Oryginalny tytuł ogłoszenia
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Rasagilin, ATC N04BD02
Ocena szansy
Skąd ta ocena?
Szansa
62 / 100
Złożoność
48 / 100
Czynniki ryzyka
Paper submissions are only timely if the complete original documents arrive by the 10th of the month after prior transm...
The notice requires a signed declaration of reliability and indicates that only pharmaceutical companies can contract;...
Submission deadline in 8 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Moderate opportunityKluczowe fakty
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Non-exclusive open-house rebate agreements for Rasagilin, ATC N04BD02.
- Supply of pharmaceutical products under fixed, pre-defined contract terms.
Pokaż pełne podsumowanie
This is an open-house pharmaceutical supply arrangement for Rasagilin (ATC N04BD02) offered by AOK Bayern. It is not a competitive award procedure: the notice states that all interested pharmaceutical companies meeting the stated suitability requirement can join on identical, non-negotiable terms. The contract period runs from 01.11.2024 to 31.10.2026, with the latest possible contract conclusion on 05.09.2026. No contract value is stated. Submission is possible electronically with a qualified electronic signature or in paper form, and the notice requires German-language submission or German translation for non-German documents.
Ryzyka
Paper submissions are only timely if the complete original documents arrive by the 10th of the month after prior transm...
The notice requires a signed declaration of reliability and indicates that only pharmaceutical companies can contract;...
Submission deadline in 8 days
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- The signatory's authority must be evidenced by the commercial register extract, otherwise a power of attorney must be provided.
Administrative
- Submit a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submit the completed and signed contract and the completed and signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Zamawiający
Lokalizacja
München, DEU
Strona
Profil zamawiającego
Identyfikator
DE811695320
Działalność
Health
Części (1)
LOT-0001
Open-house rebate agreement for Rasagilin
Single lot covering non-exclusive open-house rebate agreements for the medicinal product Rasagilin, ATC N04BD02. The lot is for pharmaceutical products (CPV 33600000) and performance is in Germany, specifically DE212. The notice text indicates the contract terms are fixed in advance and not individually negotiable.
Lokalizacja
Czas trwania
Kategoria
Termin
Szczegóły kryteriów
Siehe kurze Beschreibung
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny tytuł części
Open house Arzneimittelrabattverträge Rasagilin, ATC N04BD02
Oryginalny opis TED
Siehe kurze Beschreibung
Szczegóły zamówienia
- Data publikacji
- 16 Sep 2024
- Języki
- German
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 556500-2024
Dokumenty (2)
Podobne przetargi
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Ocena szansy
Skąd ta ocena?
Szansa
62 / 100
Złożoność
48 / 100
Czynniki ryzyka
Paper submissions are only timely if the complete original documents arrive by the 10th of the month after prior transm...
The notice requires a signed declaration of reliability and indicates that only pharmaceutical companies can contract;...
Submission deadline in 8 days
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications